This graph shows the enterprise value for pure play pharmaceutical peer set from 2005 to 2013 . In 2005 , the value was of just under 1.4 trillion U.S. dollars and by 2008 the value reached the lowest point with some 1.1 trillion . As of October 2013 , the enterprise value of the selected pharmaceutical companies stood at some 1.6 trillion U.S. dollars .
